LivaNova (LIVN) Long-Term Investments (2015 - 2026)
LivaNova (LIVN) reported Long-Term Investments of $38.3 million for Q1 2026, up 122.67% on a YoY basis from $17.2 million in Q1 2025, and up 88.64% sequentially from $20.3 million in Q4 2025.
LivaNova (LIVN) Long-Term Investments (2015 - 2026) Analysis & Trends
LivaNova (LIVN) has 12 years of Long-Term Investments data on file, last reported at $38.3 million in Q1 2026.
- For the quarter ending Q1 2026, Long-Term Investments rose 122.67% year-over-year to $38.3 million; the trailing twelve-month figure through Mar 2026 stood at $38.3 million (up 122.67% YoY), and the FY2025 full-year result was $20.3 million, down 19.11% from the prior year.
- Long-Term Investments grew to $38.3 million in Q1 2026, from $20.3 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $61.6 million in Q2 2022 to a low of $16.2 million in Q2 2025.
- A 5-year average of $33.0 million and a median of $31.0 million in 2023 frame the typical range for Long-Term Investments.
- Across the five-year window, Long-Term Investments jumped 227.71% in 2022 and plunged 59.14% in 2025, its largest moves.
- Tracing LIVN's Long-Term Investments over 5 years: stood at $54.4 million in 2022, then slumped by 58.0% to $22.8 million in 2023, then increased by 9.81% to $25.1 million in 2024, then slipped by 19.11% to $20.3 million in 2025, then jumped by 88.64% to $38.3 million in 2026.
- Business Quant data shows LIVN's Long-Term Investments at $38.3 million in Q1 2026, $20.3 million in Q4 2025, and $28.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.09 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 285.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 166.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 121.00 Mn |
| 10 | LivaNova | 4.30 Bn | 3.76 Bn | 243.75 Mn | 38.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.28 Mn |
| Dec 31, 2025 | 20.29 Mn |
| Sep 30, 2025 | 28.01 Mn |
| Jun 30, 2025 | 16.16 Mn |
| Mar 31, 2025 | 17.19 Mn |
| Dec 31, 2024 | 25.08 Mn |
| Sep 30, 2024 | 35.37 Mn |
| Jun 30, 2024 | 39.55 Mn |
| Mar 31, 2024 | 41.62 Mn |
| Dec 31, 2023 | 22.84 Mn |
| Sep 30, 2023 | 22.70 Mn |
| Jun 30, 2023 | 42.03 Mn |
| Mar 31, 2023 | 31.01 Mn |
| Dec 31, 2022 | 54.39 Mn |
| Sep 30, 2022 | 48.22 Mn |
| Jun 30, 2022 | 61.61 Mn |
| Mar 31, 2022 | 16.75 Mn |
| Dec 31, 2021 | 16.60 Mn |
| Sep 30, 2021 | 16.58 Mn |
| Mar 31, 2021 | 36.77 Mn |